Free Trial

MorphoSys (MPSYF) SEC Filings & 10K Form

MorphoSys logo
$73.27 0.00 (0.00%)
As of 11/21/2024

Recent MorphoSys SEC Filings

DateFilerForm TypeView
10/17/2024
3:54 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 15-12G
10/04/2024
3:21 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:24 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:27 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:30 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:33 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:36 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:18 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:16 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form POSASR
08/27/2024
9:14 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/07/2024
3:51 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9/A
08/07/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/05/2024
7:14 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/01/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/31/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/30/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/29/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:05 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
07/18/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/18/2024
10:25 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
3:20 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/05/2024
5:48 AM
MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9
07/05/2024
5:02 AM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
07/02/2024
9:18 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/21/2024
9:07 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:41 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:33 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC14D9C
06/20/2024
2:38 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
06/17/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
11:06 AM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 13G/A
06/10/2024
10:01 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
3:36 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2024
9:22 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
Why Elon put $51 million into this (Ad)

Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists

06/04/2024
9:17 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
9:17 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
9:17 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
9:16 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
9:13 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
1:19 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9/A
05/23/2024
9:11 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
8:04 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:07 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2024
9:15 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
3:43 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9/A
05/16/2024
3:31 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/16/2024
9:11 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
9:27 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
9:19 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
9:31 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2024
9:08 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
3:45 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/07/2024
9:24 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/06/2024
9:07 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2024
9:29 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
3:31 PM
MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/02/2024
9:43 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
9:07 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:57 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
3:15 PM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
9:17 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
9:11 AM
MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:MPSYF) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners